PVLA vs TVTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PVLA Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TVTX counters with relative strength in Valuation. Fundamentally, PVLA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TVTX at 9.3x Forward P/E and -3.1% operating margin (+36.2% YoY). In options structure, PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against TVTX sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PVLA Revenue | TVTX Revenue | PVLA Op. Margin | TVTX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $30M | $160M | -113.1% | -48.7% | TVTX |
| FY2019 | $40M | $180M | -62.2% | -78.3% | PVLA |
| FY2020 | $30M | $200M | -115.7% | -88.8% | TVTX |
| FY2021 | $30M | $130M | -165.0% | -151.3% | TVTX |
| FY2022 | $30M | $110M | -167.8% | -292.2% | PVLA |
| FY2023 | $40M | $150M | -27.7% | -267.2% | PVLA |
| FY2024 | N/A | $230M | N/A | -138.9% | TVTX |
| FY2025 | N/A | $490M | N/A | -12.8% | TVTX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PVLA | TVTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.2B | $4.9B | Larger Scale | TVTX |
| Trailing P/E Ratio Valuation | N/M | 25.8x | Lower Multiple | TVTX |
| Forward P/E Ratio Valuation | N/M | 9.3x | Lower Multiple | TVTX |
| Revenue Growth (YoY) Growth | +0.0% | +36.2% | Higher Growth | TVTX |
| Operating Margin (TTM) Profitability | 0.0% | -3.1% | Higher Margin | PVLA |
| Net Profit Margin Profitability | 0.0% | -18.7% | Higher Margin | PVLA |
| Return on Equity (ROE) Capital Efficiency | -63.4% | -321.2% | Higher ROE | PVLA |
| 52-Week Range Position Momentum | 68% ($72โ$180) | 59% ($23โ$69) | Stronger Trend | PVLA |
| Beta / 30D Volatility Risk Regime | 1.66ฮฒ ยท 75% Vol | 1.39ฮฒ ยท 44% Vol | Lower Realized Risk | TVTX |
| Unified Institutional Score Composite Signal | 48.2 / 100 (HOLD) | 60.4 / 100 (BUY) | Higher Composite | TVTX |